Clinical Trial Update: The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department [Phase 4]

View source ↗

Summary

This document outlines a Phase 4 clinical trial evaluating ferric carboxymaltose for treating iron deficiency anemia in pediatric patients in the emergency depa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia
• Iron Deficiency Anemia After Gastric Bypass
• Iron Deficiency Anemia Due to Dietary Causes
• Iron Deficiency Anemia Secondary to Inflammatory Bowel Disease
• Iron Deficiency Anemia in Non-dialysis Dependent Chronic Kidney Disease

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Children's Hospital of Orange County | Conditions: Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease, Iron Deficiency Anaemia Due to Dietary Causes | Phase 4 | Status: NOT_YET_RECRUITING